Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASALogin to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Tissue-Free vs Tumor-Informed Circulating Tumor DNA Assays in Early Triple Negative Breast Cancer | 0 | 12.99 | 13-08-2026 |
| 2 | Scientists uncover the hidden nerve network fueling breast cancer | 0 | 8.15 | 17-08-2026 |
| 3 | Comprehensive genomic profiling with subsequent molecularly guided therapy improves outcomes over platinum-based chemotherapy in previously untreated, unfavourable CUP | 0 | 16.41 | 22-09-2026 |
| 4 | FDA Approves Trodelvy — A Breakthrough Treatment For One Of The Deadliest Breast Cancers | 8 | 7 | 30-06-2026 |
| 5 | В РФ зарегистрировали препарат против тройного негативного рака молочной железы | 0 | 8.1 | 19-08-2026 |
| 6 | PARP Inhibitors for Breast Cancer Treatment | 0 | 5.63 | 01-05-2024 |
| 7 | Gut bacteria may influence estrogen-related cancers, review finds | 0 | 5 | 06-07-2026 |
| 8 | Gut bacteria may influence estrogen-related cancers, review finds | 0 | 7 | 06-07-2026 |
| 9 | Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer | 0 | 7 | 25-06-2026 |